JoVE Logo

Zaloguj się

Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

W tym Artykule

  • Podsumowanie
  • Streszczenie
  • Wprowadzenie
  • Protokół
  • Wyniki
  • Dyskusje
  • Ujawnienia
  • Podziękowania
  • Materiały
  • Odniesienia
  • Przedruki i uprawnienia

Podsumowanie

Here, we present a detailed protocol to detect and quantify protein levels during craniofacial morphogenesis/pathogenesis by immunostaining using mouse craniofacial tissues as examples. In addition, we describe a method for preparation and cryosectioning of undecalcified hard tissues from young mice for immunostaining.

Streszczenie

Tissue immunostaining provides highly specific and reliable detection of proteins of interest within a given tissue. Here we describe a complete and simple protocol to detect protein expression during craniofacial morphogenesis/pathogenesis using mouse craniofacial tissues as examples. The protocol consists of preparation and cryosectioning of tissues, indirect immunofluorescence, image acquisition, and quantification. In addition, a method for preparation and cryosectioning of undecalcified hard tissues for immunostaining is described, using craniofacial tissues and long bones as examples. Those methods are key to determine the protein expression and morphological/anatomical changes in various tissues during craniofacial morphogenesis/pathogenesis. They are also applicable to other tissues with appropriate modifications. Knowledge of the histology and high quality of sections are critical to draw scientific conclusions from experimental outcomes. Potential limitations of this methodology include but are not limited to specificity of antibodies and difficulties of quantification, which are also discussed here.

Wprowadzenie

The face is a key part of human identity, and is composed of several different types of tissues, such as epithelium, muscle, bone, cartilage, tooth. Those tissues are derived from all three germ layers: ectoderm, endoderm, and mesoderm1,2. For proper patterning and development of craniofacial tissues, cell proliferation, death and differentiation need to be highly coordinated and regulated by specific signaling pathways, such as Wnt, Fgf, Hh and Bmp pathways3,4,5. Defects in proliferation, survival or differentiation of cells will lead to craniofacial malformations, which are among the most frequently occurring congenital birth defects. Transgenic mice are useful tools to study mechanisms of craniofacial morphogenesis and pathogenesis1,2,3,4,5. Understanding the changes in craniofacial structures during development and pathogenesis will help to clarify key developmental principles as well as the mechanisms of craniofacial malformations1,2,3,4,5.

The staining of whole mount or sectioned tissues with specific antibodies is an invaluable technique for determining spatial distribution of proteins of interest 6. Formally, tissue immunostaining can rely either upon immunohistochemistry (IHC) or immunofluorescence (IF). Compared with the opaque reaction product generated with a chromogenic substrate such as 3,3’-Diaminobenzidine (DAB) by IHC, IF involves the use of fluorescent conjugates visible by fluorescence microscopy. Therefore, IF may clearly differentiate positive cells from background noise, and allows images to be quantitatively analyzed and enhanced in a straightforward fashion by software such as ImageJ and Adobe Photoshop7,8. The whole mount staining approach works on small blocks of tissue (less than 5 mm thick), which can provide three-dimensional information about the location of proteins/antigens without the need for reconstruction from sections9,10. However, compared with tissue sections, whole mount immunostaining is time consuming and requires large volumes of antibody solutions. Not all antibodies are compatible with the basic whole mount approach. In addition, the incomplete penetration of antibodies will result in uneven staining or false negative staining. Here we will focus on the immunofluorescence detection of proteins/antigens on sectioned tissues. For hard tissues (eg, head, tooth, long bone), calcium deposition during development/pathogenesis makes the sample difficult to section and easily rinsed off during immunostaining treatment11,12. Most of the currently available protocols decalcify hard tissues before embedding to make sectioning easier, which is time consuming and can destroy morphology and antigens of samples if handled improperly11,12. To overcome the issues, we optimized an approach for cryosectioning of hard tissues without decalcification, leading to improved visualization of their morphology and distribution of signaling proteins.

The protocol described here is being used to determine morphometric and histological changes in the craniofacial tissues of BMP transgenic mice. Specifically, the protocol includes (1) harvesting and dissecting head tissues, (2) section and immunostaining of experimental markers (Ki67, pSmad1/5/9) along with TUNEL staining, (3) imaging the sections using fluorescence microscope, and finally (4) analyzing and quantifying the results. The protocol to prepare and cryosection hard tissues without decalcification is also described13. Those methods are optimized for craniofacial tissues. They are also applicable to other tissues from various ages of samples with appropriate modifications.

Protokół

All mouse experiments were carried out in accordance with University of Michigan guidelines covering the humane care and use of animals in research. All animal procedures used in this study were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Michigan (Protocol #PRO00007715).

1. Tissue Preparation

  1. Preparation of embryonic tissues
    1. Prepare one 10 cm dish and several 3.5 cm dishes containing phosphate buffered saline (PBS), and one 12-well culture plate containing 2 mL 4% paraformaldehyde (PFA) in PBS in each well for each pregnant mouse. Place all Petri dishes and the plate on ice.
      NOTE: Handle 4% PFA in a fume hood.
    2. Dissect embryos from pregnant mice in ice-cold PBS with forceps and scissors as previously described14.
      1. Briefly, euthanize a pregnant mouse with CO2, grab the skin below the center of the belly with forceps and cut through the skin only, then gently pull at the skin to separate it from the underlying the abdominal muscle wall.
      2. Next, cut into the abdominal cavity following the same line of the skin incision. Remove the uterus containing a string of embryos and remove the embryos by gently cutting away the uterine wall. The extraembryonic tissues such as the yolk sac and amnion will be removed.
      3. Cut and isolate head from each embryo.
    3. Transfer each head into each well of a 12-well plate containing 4% PFA with a plastic transfer pipette or forceps. Fix samples in 4% PFA at 4 °C for 4 h. Rinse samples in PBS at 4 °C with gentle shaking for 12 h.
      NOTE: For embryos younger than embryonic day 16.5 (E16.5), fix embryo heads with 4% PFA directly after isolation. For embryos at E16.5 or later, remove to discard skin and adipose tissue from the heads and rinse several times in ice cold PBS before fixation.
    4. Cryoprotect heads.
      1. Transfer each head into a new 12-well plate containing 2 mL of 30% sucrose in PBS using a plastic transfer pipette or forceps. Agitate gently at 4 °C until the head sinks to the bottom of the dish.
    5. Embed heads.
      1. Transfer the cryoprotected head into a mold containing Optimal Cutting Temperature (OCT) compound. Equilibrate samples in OCT for several minutes. Adjust the location and direction of samples with forceps.
      2. Place the mold on dry ice to freeze. Store resulting cryomolds in a plastic bag at -80 °C until ready for cryosectioning.
        NOTE: The trimmed side of the samples must face the bottom of the embedding mold.
  2. Preparation of postnatal undecalcified hard tissues
    1. Euthanize at 3 week or 3 month old mouse with CO2. Remove the skin and adipose tissues. Cut and isolate the head or long bones from the mouse.
    2. Fix and cryoprotect the head or long bone of mice as described in steps 1.1.3–1.1.4.
    3. Embed in 8% gelatin in a similar manner as step 1.1.5. Keep the cryomolds in a plastic bag at -80 °C until cryosectioning.
      NOTE: Decalcification is not necessary here. To prepare 8% gelatin, mix 8 g of gelatin with 100 mL of PBS and boil using a microwave. Be aware that the mixture boils over easily.

2. Cryosectioning

  1. Set cryostat temperature to -18 °C for soft tissues embedded in OCT or -25 °C and lower for undecalcified hard tissues embedded in gelatin. Keep samples in the cryostat chamber for about 30 min to equilibrate to the cryostat temperature.
  2. Expel the block from the cryomold. Freeze the block onto the specimen chuck (tissue holder) via mounting with an OCT drop. Keep the trimmed side of the sample furthest from the chuck (facing the operator).
  3. Load the block-mounted chuck onto the cryostat object holder. Adjust the blade holder to make the angle of the blade 3°–5° relative to the sample.
  4. Collect 10 µm sections onto coated microscope slides. Dry sections completely at RT, then store them at -80 °C.

3. Histological Staining and Microscopic Imaging

  1. Immunofluorescence staining
    1. Take out slides from -80 °C. Keep slides at RT for 1 h to airdry sections. Rinse slides in 0.1% PBST (0.1% Polyethylene glycol tert-octylphenyl ether in PBS; see Table of Materials) three times for 5 min each to wash out OCT and permeabilize sections.
    2. Optionally, perform antigen retrieval (optional).
      1. Preheat citrate buffer (10 mM sodium citrate pH 6) in the staining dish with steamer or water bath to 95–100 °C. Immerse slides in the citrate buffer, incubate for 10 min.
      2. Take the staining dish out from steamer or water bath to RT. Cool the slides at RT for 20 min or longer15.
        NOTE: As alternatives, use Tris-EDTA buffer (10 mM Tris base, 1mM EDTA, 0.05% Tween 20, pH 9.0) or EDTA buffer (1 mM EDTA, 0.05% Tween 20, pH 8.0) for heat-induced antigen retrieval. Use a pressure cooker, microwave, or water bath for heat-induced antigen retrieval, in addition to the hot steamer. An enzyme-induced antigen retrieval using trypsin or pepsin is another alternative. Optimize the concentration and treatment time of enzymatic retrieval to avoid damaging sections. Optimize the antigen retrieval method for each antibody/antigen combination.
    3. Incubate each slide with 200 μL of blocking solution (5% donkey serum diluted in 0.1% PBST) at RT for 30 min, then remove the blocking solution without rinse.
    4. Incubate each slide with 100 μL of primary antibody or antibodies diluted in blocking solution for 1 h at RT or O/N at 4 °C. Rinse slides with PBS three times for 10 min each at RT.
    5. Incubate each slide with 100 μL of secondary antibody diluted in blocking solution for 1 h at RT. Rinse slides in PBS three times for 10 min each at RT. Protect slides from light.
    6. Mount slides.
      1. Add two drops of anti-fade medium with DAPI (4', 6-diamidino-2-phenylindole) on the slide. Then cover with a coverslip.
      2. Store at 4 °C in dark until ready to image.
        NOTE: As an alternative, label the nuclei with DAPI or Hoechst 33324 dye diluted 1:2,000 in PBS at RT first, then mount with glycerol.
  2. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining.
    NOTE: Double-stranded DNA with 3’-hydroxyl termini (3'OH DNA termini) will form during apoptosis in the cell. Here, we provide a protocol that label the free 3'OH DNA termini in situ via labeling DNA fragments with the digoxigenin-nucleotide utilizing terminal deoxynucleotidyl transferase (TdT) by specific staining using a commercial kit (see Table of Materials).
    1. Optionally, stain sections with primary and Alexa Fluor-488 labeled secondary antibodies prior to the TUNEL staining. Rinse the slides in PBS three times for 10 min each.
      NOTE: This step is optional for a double staining of a protein and TUNEL in the same slide.
    2. Incubate each slide with 100 μL Proteinase K (10 µg/mL in 10 mM Tris pH 7.5 and 5 mM EDTA) for 5 min at RT. Rinse slides with PBS three times for 10 min each at RT.
      NOTE: Adjust the incubation time and temperature of Proteinase K for each tissue type. For 10 µm sections of embryo heads fixed in 4% PFA, incubate for 5 min at RT. In addition to the method using Proteinase K, use alternative treatments as needed, including (1) freshly prepared 0.1% Polyethylene glycol tert-octylphenyl ether, 0.1% sodium citrate, 10 min at 37 °C; (2) 0.25%–0.5% Pepsin in HCl (pH 2) or 0.25% trypsin, 10 min at 37 °C; and (3) microwave irradiation with 0.1 M citrate buffer (pH 6).
    3. Apply 200 μL of blocking solution (5% donkey serum diluted in 0.1% PBST) to each slide, incubate at RT for 30 min, tap off the blocking solution without rinse.
    4. Apply 50 µL of the equilibration buffer supplied by the kit to each slide at RT for at least 10 s. Tap off the buffer without rinse.
    5. Prepare reaction mixture (working strength TdT enzyme) by mixing TdT Enzyme with the reaction buffer supplied by the kit at the ratio of 3:7. Apply 50 µL of the reaction mixture to each slide, and incubate at 37 °C for 1 h. Tap off the buffer without rinsing.
    6. Apply 200 µL of the stop buffer (1:30 diluted in ddH2O) supplied by the kit to each slide, then incubate at RT for 10 min. Rinse slides with PBS three times for 10 min each.
    7. Label with Rhodamine antibody.
      1. Apply 50 µL of pre-warmed (RT) anti-digoxigenin conjugate (rhodamine) (1:1 diluted in blocking solution) to each slide. Incubate at RT for 30 min in dark.
      2. Rinse slides with PBS three times for 10 min each. Mount slides as step 3.1.6.

4. Imaging Acquisition

  1. Use positive controls (tissues positive for the target antigen) to check the signal labeling and negative controls (omit the primary antibody, isotype control, or tissues negative for the target antigen) to evaluate the background of images under the fluorescent microscope.
  2. Set the equipment and camera conditions (exposures and other general settings) for imaging based on the signal intensity of negative and positive controls.
    NOTE: These conditions vary by (1) cameras and microscopes used for imaging, (2) antibodies, and (3) tissues for each experiment. Common conditions used for craniofacial tissues are ISO 200 with an exposure time ranging from 1/100 s to 1 s depend on the quality and specificity of antibodies. Appropriate magnifications vary depending on the size of the samples and purpose of experiments.
  3. Acquire images with conventional epifluorescence microscope or confocal microscope. Acquire images (including those of corresponding controls) in the same conditions for each color channel. Save images with the same format (tiff is best to preserve information).

5. Fluorescence Quantification

NOTE: Statistically comparing the staining between different groups will be more informative in many cases. With the immunofluorescence images, quantify the relative level of the protein by measuring signal density, counting positive cells, or calculating positive areas. For statistical analysis, the minimum number of biologically independent samples is 3. A typical method is to generate at least three sections from each sample and take images for at least three representative areas in each section.

  1. Quantification of fluorescence intensity using ImageJ
    1. Open the software, and use Analyze > Set Measurements to check that only Area and Integrated Density are selected. Use File > Open to open images to be analyzed.
    2. Use Toolbar to select either the square or circle icon on the far left. Select the area to be analyzed on the image using the selection tool. Use Analyze > Measure to get the readout of the selected area and integrated density in the Results window. Select a region next to a positive cell that has no fluorescence to read out the background.
    3. Repeat step 5.1.2 to analyze other images. Adjusted the area to be analyzed to match with that of the first image.
    4. Copy all the data in the Results window and paste into a spreadsheet when finished analyzing.
    5. Calculate the corrected fluorescence intensity (CTCF) as Integrated Density — (Area of selected cell x Mean fluorescence of background readings). Compare the difference of the corrected total cell fluorescence between samples and make a graph.
  2. Quantification of the positive cell number of fluorescent images using ImageJ
    1. Manual cell counting.
      1. Use ImageJ > Plugins > Analysis to install the Cell Counter plugin.
      2. Use File > Open to open images to be analyzed. Use Plugins > Analysis > Cell counter to open the Counter window and the Results window.
        NOTE: Cell counter does not work on stacks. For counting stacks, plugin Plot Z Axis Profile, then use Image > Stacks > Plot Z Axis Profile to monitor the intensity of a moving ROI using a particle tracking tool. This tool can be either manual or automatic.
      3. Clicking one of buttons at the bottom of the Counter window to initiate counting. Click directly on a cell/object to be count until finishing.
      4. Click the Results button in the Count window. The total number of cells counted will be shown in the Results window. Save the result log as spreadsheet and analyze.
    2. Automated cell counting.
      1. Use File > Open to open images to be analyzed. Convert the RGB image into a grey scale image before proceeding.
      2. Use Image > Adjust > Threshold to select all the areas that need to be counted.
      3. Use Analyze > Analyze Particles to get the number of cells/particles. Set a range of the valid particle size (e.g., 100-Infinity) instead of the default of 0-Infinity to count cells/particles within a specific range. Save the result log as spreadsheet and analyze.
        NOTE:
        To get other information from the image, besides area, go to Analyze > Set Measurements and select the box next to the information needed.

Wyniki

Embryonic craniofacial tissue sections
Following the above steps, heads were dissected from control (P0-Cre) or mutant (constitutively activated Bmpr1a in neural crest cells, P0-Cre; caBmpr1a) embryos at embryonic day (E) 16.5 or 18.5. After fixing in 4% PFA for 4 h, samples were embedded in OCT and cryosectioned coronally. Resulted sections were immunostained with antibodies against pSmad1/5/9 (downstream BMP signaling factors) or Ki67 (a cell pro...

Dyskusje

Here we provide a detailed protocol for preparation of mouse head and undecalcified bone tissues, and cryosectioning for immunostaining of cell proliferation, cell death, and BMP signaling markers. We also detail the strategy for obtaining quantitative data from immunofluorescent images. Those methods can also be applicable to other tissues with appropriate modifications.

Conditions for tissue preparation vary by the size and type of tissues. The fixation and cryoprotection time usually need s...

Ujawnienia

The authors have nothing to disclose.

Podziękowania

This work was supported by the National Institutes of Health (R01DE020843 to Y.M.), the International FOP Association (Y.M.), and a grant-in-aid from the National Natural Science Foundation of China (31500788 to J.Y.).

Materiały

NameCompanyCatalog NumberComments
Adhesive tapeLeica#39475214
Alexa fluor 488-goat anti-Rabbit secondary antibodyInvitrogenA-11034
Antifade Mountant with DAPIInvitrogenP36931
Bovine serum albuminSigmaA2153
CoverslipsFisher Brand12-545-E
CryostatLeicaCM1850
EDTASigmaE6758
Fluorescence microscopeOlympusBX51
GelatinSigmaG1890
In Situ Cell Death Detection KitMilliporeS7165
Microscope slidesFisher Brand12-550-15
OCT CompoundFisher Healthcare23-730-571
Paraformaldehyde (PFA)SigmaP6148 
Phosphate buffered saline (PBS)SigmaP4417
Polyethylene glycol tert-octylphenyl etherSigmaT9284Triton X-100
Proteinase KInvitrogenAM2542
Rabbit anti-Ki67 antibodyCell Signaling Technology9129Lot#:3; RRID:AB_2687446
Rabbit anti-pSmad1/5/9 antibodyCell Signaling Technology13820Lot#:3; RRID:AB_2493181
Sodium citrateSigma1613859
SucroseSigmaS9378
TrisSigma10708976001

Odniesienia

  1. Trinh, L. e. A., Fraser, S. E. Imaging the cell and molecular dynamics of craniofacial development: challenges and new opportunities in imaging developmental tissue patterning. Current Topics in Developmental Biology. 115, 599-629 (2015).
  2. Marcucio, R., et al. Facial morphogenesis: physical and molecular interactions between the brain and the face. Current Topics in Developmental Biology. 115, 299-320 (2015).
  3. Graf, D., et al. Common mechanisms in development and disease: BMP signaling in craniofacial development. Cytokine & Growth Factor Reviews. 27, 129-139 (2016).
  4. Snider, T. N., Mishina, Y. Cranial neural crest cell contribution to craniofacial formation, pathology, and future directions in tissue engineering. Birth Defects Research Part C: Embryo Today. 102 (3), 324-332 (2014).
  5. Mishina, Y., Snider, T. N. Neural crest cell signaling pathways critical to cranial bone development and pathology. Experimental Cell Research. 325 (2), 138-147 (2014).
  6. Van Hecke, D. Routine Immunohistochemical Staining Today: Choices to Make, Challenges to Take. Journal of Histotechnology. 1, 45-54 (2002).
  7. Xiao, C., Dan-Bi, C. Double staining immunohistochemistry. North American Journal of Medical Sciences. 2 (5), 241-245 (2010).
  8. Zongli, Q., et al. Comparison of immunofluorescence and immunohistochemical staining with anti-insulin antibodies on formalin-fixed paraffin-embedded human pancreatic tissue microarray sections. International Journal of Clinical and Experimental Pathology. 10 (3), 3671-3676 (2017).
  9. Montgomery, S. C., Cox, B. C. Whole mount dissection and immunofluorescence of the adult mouse cochlea. Journal of Visualized Experiments. (107), e53561 (2016).
  10. Dun, X. P., Parkinson, D. B. Whole mount immunostaining on mouse sciatic nerves to visualize events of peripheral nerve regeneration. Methods in Molecular Biology. 1739, 339-348 (2018).
  11. Akkiraju, H., et al. An Improved Immunostaining and Imaging Methodology to Determine Cell and Protein Distributions within the Bone Environment. Journal of Histochemistry & Cytochemistry. 64 (3), 168-178 (2016).
  12. González-Chávez, S. A., et al. Assessment of different decalcifying protocols on Osteopontin and Osteocalcin immunostaining in whole bone specimens of arthritis rat model by confocal immunofluorescence. International Journal of Clinical and Experimental Pathology. 6 (10), 1972-1983 (2013).
  13. Kapelsohn, K. Improved Methods for Cutting, Mounting, and Staining Tissue for Neural Histology. Protocol Exchange. , (2015).
  14. Kalaskar, V. K., Lauderdale, J. D. Mouse embryonic development in a serum-free whole embryo culture system. Journal of Visualized Experiments. (85), e50803 (2014).
  15. Shi, S. R., et al. Antigen retrieval techniques: current perspectives. Journal of Histochemistry & Cytochemistry. 49 (8), 931-937 (2001).
  16. Adell, T., et al. Immunohistochemistry on paraffin-embedded planarian tissue sections. Methods in Molecular Biology. 1774, 367-378 (2018).
  17. Griffioen, H. A., et al. Gelatin embedding to preserve lesion-damaged hypothalami and intracerebroventricular grafts for vibratome slicing and immunocytochemistry. Journal of Neuroscience Methods. 43, 43-47 (1992).
  18. Sarkar, S., et al. In situ demonstration of Fluoro-Turquoise conjugated gelatin for visualizing brain vasculature and endothelial cells and their characterization in normal and kainic acid exposed animals. Journal of Neuroscience Methods. 219 (2), 276-284 (2013).
  19. Oorschot, V., et al. A novel flat‐embedding method to prepare ultrathin cryosections from cultured cells in their in situ orientation. Journal of Histochemistry & Cytochemistry. 50, 1067-1080 (2002).

Przedruki i uprawnienia

Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE

Zapytaj o uprawnienia

Przeglądaj więcej artyków

Tissue PreparationImmunostainingImmunofluorescenceMouse Craniofacial TissuesUndecalcified BoneAntigen RetrievalHard TissuesCryoprotectionPFA FixationEmbryo DissectionPBS RinsingSucrose IncubationOptimal Cutting Temperature CompoundSample Embedding

This article has been published

Video Coming Soon

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone